Showing results (4041-4050 of 5,597) with videos related to
Sort By:
Pageof 560
Journal of Cancer|September 23, 2024
SCAMP1 silencing inhibits proliferation by attenuating multiple pro-survival signaling pathways in gastric cancerGang Ma, Yang Yang, Fenglin Cai, et al.Journal of Cancer|September 23, 2024
Lactate Metabolism Subtypes Analysis Reveals CCDC80 as a Novel Prognostic Biomarker in Gastric CancerXiang Li, Yaqi DuJournal of Cancer|September 23, 2024
Eosinophil-Associated Genes are Potential Biomarkers for Hepatocellular Carcinoma PrognosisQinghao Wang, Zixin Zhang, Hao Zhou, et al.Journal of Cancer|September 23, 2024
PD-1 Inhibitors Combined with Chemotherapy versus Re-irradiation/chemoradiotherapy for Unresectable Locally Recurrent T3-4 Nasopharyngeal Carcinoma: A Retrospective StudyTong-Xin Liu, Quan-Quan Sun, Yong-Hong Hua, et al.Journal of Cancer|September 23, 2024
A survival nomogram involving nutritional-inflammatory indicators for cervical cancer patients receiving adjuvant radiotherapyShanshan Wang, Mengli Zhao, Zhongrong Gao, et al.Journal of Cancer|September 9, 2024
circTP63 promotes prostate cancer progression via miR-421/VAMP associated protein A axisJianfeng Xu, Siwei Xu, Weihui Liu, et al.Journal of Cancer|September 9, 2024
CDH3 Is an Effective Serum Biomarker of Colorectal Cancer Distant Metastasis PatientsJiayin Song, Yu Jin, Shuoqing Fan, et al.Journal of Cancer|September 9, 2024
Analysis of ZNF208 Polymorphisms on the Clinicopathologic Characteristics of Asian Patients with Hepatocellular CarcinomaYi-Chung Chien, Hsiang-Lin Lee, Whei-Ling Chiang, et al.Journal of Cancer|September 9, 2024
Erratum: TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a: ErratumWeiwei Liu, Qian Feng, Wenjun Liao, et al.Journal of Cancer|March 4, 2024
Assessment the value of Pyroptosis-Associated Gasdermin family genes in hepatocellular carcinoma: A Multi-Omics Comprehensive AnalysisChanghong Wei, Jiamin Zhou, Wenfu Tao, et al.Pageof 560